Study: MDMA therapy for PTSD shows positive results 04:26. The Food and Drug Administration declined Friday to approve an application to treat post-traumatic stress disorder using the drug ...

The U.S. Food and Drug Administration (FDA) has decided not to approve a psychedelic treatment -- along with therapy -- to treat post-traumatic stress disorder (PTSD), according to Lykos ...

HEALTH FDA rejects MDMA as psychedelic-based treatment for mental health, PTSD The agency has requested that Lykos Therapeutics conduct another Phase 3 trial to confirm safety and efficacy ...

In June, the FDA's Psychopharmacologic Drugs Advisory Committeevoted 9-2 against MDMA as an effective treatment for PTSD patients, and 10-1 that the drug's benefits do not outweigh the risks.

FDA rejects MDMA-assisted therapy for PTSD. The decision came after the agency's advisory committee said in June that there wasn't enough evidence the therapy was safe or effective.

FDA rejects MDMA, disappointing ... Lykos Therapeutics received word from the Food and Drug Administration that the agency has decided not to approve MDMA-assisted therapy for PTSD at this time.

Despite the FDA's rejection of MDMA-assisted therapy, Lykos Therapeutics plans to push ahead for approval, despite internal turmoil and layoffs of 75% of company staff.

FDA Rejects MDMA Treatment for PTSD; Setbacks and New Directions. by: Madeline Campbell of Womble Bond Dickinson (US) LLP - Law Meets Science. Tuesday, September 10, 2024.

Kaya Holdings criticizes the FDA's rejection of MDMA therapy for PTSD, proposing psilocybin as a viable alternative, particularly in light of Oregon's legal framework. España. India.

Drugmaker Lykos Therapeutics had asked the FDA to approve its MDMA capsules as part of a therapy regimen for treating PTSD. It says another study will take "several years." ...

The U.S. Food and Drug Administration (FDA) has decided not to approve a psychedelic treatment -- along with therapy -- to ...

In June 2024, an FDA advisory committee voted overwhelmingly against the idea that the relevant clinical trials had proved the efficacy of MDMA for the treatment of PTSD.